FDA Study Of Botox Safety Deepens Allergan's Frown
Still smarting from recent public scrutiny from a consumer advocacy group over Botox, Allergan Inc. has been hit with more bad news. The U.S. Food and Drug Administration announced Friday it...To view the full article, register now.
Already a subscriber? Click here to view full article